Today Assembly Biosciences Inc (NASDAQ:ASMB) Reported Decrease in Shorted Shares

October 2, 2018 - By olga

The stock of Assembly Biosciences Inc (NASDAQ:ASMB) registered a decrease of 4.66% in short interest. ASMB’s total short interest was 475,100 shares in October as published by FINRA. Its down 4.66% from 498,300 shares, reported previously. With 135,200 shares average volume, it will take short sellers 4 days to cover their ASMB’s short positions.

The stock decreased 1.40% or $0.51 during the last trading session, reaching $35.94. About 99,003 shares traded. Assembly Biosciences, Inc. (NASDAQ:ASMB) has risen 26.62% since October 2, 2017 and is uptrending. It has outperformed by 11.00% the S&P500.

Assembly Biosciences, Inc., a clinical stage biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics to restore health to a dysbiotic microbiome in the United States. The company has market cap of $914.55 million. It is involved in developing core protein allosteric modulators that modulate the HBV core protein at various points in the viral lifecycle. It currently has negative earnings. The firm also develops microbiome program, a platform that includes the identification and selection process to strain isolation and growth under current good manufacturing practice conditions; and a patent pending delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract.

Assembly Biosciences, Inc. (NASDAQ:ASMB) Ratings Coverage

Among 4 analysts covering Assembly Biosciences (NASDAQ:ASMB), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Assembly Biosciences had 5 analyst reports since April 13, 2018 according to SRatingsIntel. The firm has “Neutral” rating by Chardan Capital Markets given on Friday, April 13. The firm has “Neutral” rating given on Tuesday, May 8 by FBR Capital. The stock has “Hold” rating by FBR Capital on Thursday, June 21.

Another recent and important Assembly Biosciences, Inc. (NASDAQ:ASMB) news was published by Globenewswire.com which published an article titled: “Assembly Biosciences Announces Oral Presentation at 2018 AASLD” on October 02, 2018.

Assembly Biosciences, Inc. (NASDAQ:ASMB) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>